C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61K 31/44 (2006.01) A61K 31/4745 (2006.01) A61K 31/4985 (2006.01) A61K 31/5383 (2006.01) A61P 1/04 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 11/00 (2006.01) A61P 11/06 (2006.01) A61P 17/02 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 19/06 (2006.01) A61P 19/08 (2006.01) A61P 19/10 (2006.01) A61P 21/00 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 31/00 (2006.01) A61P 31/04 (2006.01) A61P 31/06 (2006.01) A61P 31/10 (2006.01) A61
Patent
CA 2402549
Compounds of the formula (I) are suitable for the production ofpharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of I.kappa.B kinase is involved.
Les composés de formule (I) conviennent à la production de produits pharmaceutiques pour la prophylaxie et le traitement de troubles dans lesquels une activité accrue de l'I.kappa.B-kinase est impliquée.
Adams Julian
Castro Alfredo
Grenier Louis
Hancock Wayne W.
Mazdiyasni Hormoz
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Substituted beta-carbolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted beta-carbolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted beta-carbolines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2020262